| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 06/15/2000 | CA2349616A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 06/14/2000 | EP1007674A1 Testis-specific transcription factor zgcl-1 |
| 06/14/2000 | EP1007534A1 Bh3 interacting domain death agonist |
| 06/14/2000 | EP1007514A1 Heterocyclic ketones as npy y5 antagonists |
| 06/14/2000 | EP1007091A1 Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction |
| 06/14/2000 | EP1007084A1 Immunogenic lhrh compositions and methods relating thereto |
| 06/14/2000 | EP1007080A1 Sustained peptide-release formulation |
| 06/14/2000 | EP1007056A1 Method for the treatment of cystic fibrosis |
| 06/14/2000 | EP1007052A1 Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception |
| 06/14/2000 | EP1007024A1 Delayed-release dosage forms of sertraline |
| 06/14/2000 | EP1006964A1 Intrauterine chemical necrosing method, composition, and apparatus |
| 06/14/2000 | EP0845985B1 Non-steroidal sulfatase inhibitor compounds |
| 06/14/2000 | EP0820426B1 SUBSTITUTED DIBENZ[a,f]AZULENES AND METHODS OF PREPARATION |
| 06/13/2000 | US6075151 Inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related hyperlipidemia, cardiovascular disorders |
| 06/13/2000 | US6075136 Polynucleotide sequence coding a polypeptide with enzymatic activity; for treating or preventing cancer and reproductive defects; anticarciongenic agents |
| 06/13/2000 | US6075054 Antiarrhythmic pharmaceuticals having a cardioprotective component for infarct prophylaxis and infarct treatment as well as for the treatment of angina pectoris |
| 06/13/2000 | US6075037 Endothelin receptor antagonists |
| 06/13/2000 | US6074839 Transforming growth factor αHI |
| 06/13/2000 | US6074642 Reduce cell lysing ability of biological complement present in blood |
| 06/13/2000 | US6074641 Administering monoclonal antibody |
| 06/08/2000 | WO2000032752A1 Psca: prostate stem cell antigen and uses thereof |
| 06/08/2000 | WO2000032600A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives |
| 06/08/2000 | WO2000032593A1 Method of producing paroxetine hydrochloride |
| 06/08/2000 | WO2000032555A1 Derivatives of (+)-venlafaxine and methods of preparing and using the same |
| 06/08/2000 | WO2000032224A2 Calcitonin for the modulation of sperm function |
| 06/08/2000 | WO2000032222A1 Improvement of folliculogenesis |
| 06/08/2000 | WO2000032202A1 Method for obtaining and using a combination of a purine and a nitrogen monoxide donor for preventing or treating sexual dysfunction |
| 06/08/2000 | WO2000032195A1 Preparations for intraurethral administration |
| 06/08/2000 | WO2000032178A2 Use of siburamine for the treatment of disorders of the central nervous system secondary to organic impairments |
| 06/08/2000 | WO2000032171A2 Autoahesive oral transmucosal delivery dosage form |
| 06/08/2000 | WO2000015245A3 Stable liquid formulations of botulinum toxin |
| 06/08/2000 | CA2354187A1 Calcitonin for the modulation of sperm function |
| 06/08/2000 | CA2353613A1 Preparations for intraurethral administration |
| 06/08/2000 | CA2353085A1 Improvement of folliculogenesis |
| 06/08/2000 | CA2352321A1 Derivatives of (+)-venlafaxine and methods of preparing and using the same |
| 06/08/2000 | CA2342621A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives |
| 06/07/2000 | EP1005867A2 Botulinum toxins for modulating cholinergic controlled secretions |
| 06/07/2000 | EP1005538A1 Gene therapy for alleviating erectile dysfunction |
| 06/07/2000 | EP1005336A1 Improved methods and compositions for treating male erectile dysfunction |
| 06/07/2000 | CN1255497A Method for preparing pyrazo [4,3-d] pyrimidine-7-one and its intermediate |
| 06/07/2000 | CN1255375A Medicine for treating menalgia, leukorrhagia and habitual abortion |
| 06/07/2000 | CN1255348A Medicine for treating gynopathy |
| 06/07/2000 | CN1255339A Chinese-medicinal instant particles for promoting milk secretion and recovery of puerperant |
| 06/06/2000 | US6071938 Benzopyrans |
| 06/06/2000 | US6071919 Stimulate the immunological system and to induce the production of hypercellular bone marrow and extramedullary hematopoiesis; antitumor and -carcinogenic agents; autoimmune diseases; viricides; hepatitis |
| 06/06/2000 | US6071894 Sensor histidine kinase of Staphylococcus aureus |
| 06/06/2000 | US6071721 Calcium binding protein |
| 06/06/2000 | US6071531 Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
| 06/06/2000 | CA1341012C Dna sequences, recombinant dna molecules and processes for producing swine growth hormone-like polypeptides |
| 06/02/2000 | WO2000031060A1 Scavenger compounds |
| 06/02/2000 | WO2000031048A1 N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases |
| 06/02/2000 | WO2000030684A1 Medicinal compositions for periodic administration |
| 06/02/2000 | WO2000030629A2 Method of promoting cervical and vaginal secretions |
| 06/02/2000 | WO2000030623A2 Agent for lowering prolactin |
| 06/02/2000 | CA2352461A1 Pharmaceutical composition for periodic administration |
| 06/02/2000 | CA2352262A1 Method of promoting cervical and vaginal secretions |
| 06/02/2000 | CA2352144A1 Scavenger compounds |
| 06/02/2000 | CA2349721A1 N-¬4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl|-acrylamide, an irreversible inhibitor of tyrosine kinases |
| 05/31/2000 | EP1003774A1 GnRH ANTAGONISTS BEING MODIFIED IN POSITIONS 5 AND 6 |
| 05/31/2000 | EP1003763A1 83 human secreted proteins |
| 05/31/2000 | EP1003737A1 Phenyl urea and phenyl thiourea derivatives as hfgan72 antagonists |
| 05/31/2000 | EP1003545A1 Heparin-binding growth factor (hbgf) polypeptides |
| 05/31/2000 | EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 05/31/2000 | EP1003537A1 Et |
| 05/31/2000 | EP1003520A1 Method and composition for treatment of erectile dysfunction |
| 05/31/2000 | EP1003477A2 Therapeutical system for transdermal delivery of levonorgestrel |
| 05/31/2000 | EP0939651B1 Materials and methods relating to the diagnosis and treatment of pre-eclampsia |
| 05/31/2000 | DE19853476A1 Prolaktin-senkendes Mittel Prolactin-lowering agent |
| 05/31/2000 | CN1255133A 1,5-dihydro-pyrazolo [3,4-D]-pyrimidinone derivatives |
| 05/31/2000 | CN1255067A Use of secretion vector for fertility control by oral vaccination |
| 05/31/2000 | CN1255057A Aqueous pharmaceutical composition comprising active ingredient which is highly insoluble in water |
| 05/31/2000 | CN1255056A Intravaginal drug delivery devices for idminsitration of testosterone and testosterone precursors |
| 05/31/2000 | CN1052879C Health-care medical wine |
| 05/30/2000 | US6069156 Indole derivatives as cGMP-PDE inhibitors |
| 05/30/2000 | US6069150 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents |
| 05/30/2000 | US6068983 Introducing into cells a dna molecule coding for an fc receptor which is then expressed for increased phagocytic activity; combating infection and/or modulating immune complex disease |
| 05/30/2000 | US6068845 Inhibitory activity on the abnormal production of extracellular matrices in dermal fibroblasts activated with tranforming growth factor beta by administering the plant extract of a plant belonging to the genus sophora |
| 05/25/2000 | WO2000029601A1 A method for depopulating of vertebrate testis and for generation of transgenic species |
| 05/25/2000 | WO2000029580A1 Calcium binding protein |
| 05/25/2000 | WO2000029569A1 Methods of diagnosing or treating neurological diseases |
| 05/25/2000 | WO2000029443A1 Contraceptive antibody vaccines |
| 05/25/2000 | WO2000029428A2 5t4 tumour-associated antigen for use in tumour immunotherapy |
| 05/25/2000 | WO2000029405A1 Method for preparing (2s)-1-[ (2r,3s)-5- chloro-3-(2- chlorophenyl) -1-(3,4-dimethoxy benzenesulphonyl) -3-hydroxy-2, 3-dihydro-1h- indole-2-carbonyl] pyrrolidine-2- carboxamide |
| 05/25/2000 | WO2000029401A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/25/2000 | WO2000029383A1 Crystalline forms of 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide |
| 05/25/2000 | WO2000029011A1 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 05/25/2000 | WO2000028991A1 Remedies for polycystic ovary syndrome |
| 05/25/2000 | WO2000028968A1 Drug delivery device, especially for the delivery of progestins and estrogens |
| 05/25/2000 | WO2000028967A1 Drug delivery device, especially for the delivery of androgens |
| 05/25/2000 | WO2000028835A1 A method for supplying bioavailable methionine to a cow |
| 05/25/2000 | WO2000015788A3 Dna sequence encoding oncofetal ferritin protein |
| 05/25/2000 | CA2351622A1 Polypeptide |
| 05/25/2000 | CA2351187A1 Tetrahydroisoquinoline derivatives as lhrh antagonists |
| 05/25/2000 | CA2351064A1 Drug delivery device, especially for the delivery of androgens |
| 05/25/2000 | CA2350917A1 Contraceptive antibody vaccines |
| 05/25/2000 | CA2350914A1 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 05/25/2000 | CA2350520A1 Crystal forms of 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide |
| 05/25/2000 | CA2350389A1 Calcium binding protein |
| 05/25/2000 | CA2348676A1 Method for preparing (2s)-1-¬ (2r,3s)-5- chloro-3-(2- chlorophenyl) -1-(3,4-dimethoxy benzenesulphonyl) -3-hydroxy-2, 3-dihydro-1h- indole-2-carbonyl| pyrrolidine-2- carboxamide |
| 05/25/2000 | CA2348459A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |